Tags

Type your tag names separated by a space and hit enter

Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice.
Blood 1997; 90(4):1527-34Blood

Abstract

Impaired fibrinolysis, resulting from increased plasminogen activator inhibitor-1 (PAI-1) or reduced tissue-type plasminogen activator (t-PA) plasma levels, may predispose the individual to subacute thrombosis in sepsis and inflammation. The objective of these studies was to show that adenovirus-mediated gene transfer could increase systemic plasma t-PA levels and thrombolytic capacity in animal model systems. Recombinant adenovirus vectors were constructed that express either human wild type or PAI-1-resistant t-PA from the cytomegalovirus (CMV) promoter. Both t-PA-deficient (t-PA(-/-)) and PAI-1-overexpressing transgenic mice were infected by intravenous injection of these viruses. Intravenous injection of recombinant adenovirus resulted in liver gene transfer, t-PA synthesis, and secretion into the plasma. Virus dose, human t-PA antigen, and activity concentrations in plasma and extent of lysis of a 125I-fibrin-labeled pulmonary embolism were all closely correlated. Plasma t-PA antigen and activity were increased approximately 1,000-fold above normal levels. Clot lysis was significantly increased in mice injected with a t-PA-expressing virus, but not in mice injected with saline or an irrelevant adenovirus. Comparable levels of enzyme activity and clot lysis were obtained with wild type and inhibitor-resistant t-PA viruses. Adenovirus-mediated t-PA gene transfer was found to augment clot lysis as early as 4 hours after infection, but expression levels subsided within 7 days. Adenovirus-mediated transfer of a t-PA gene can effectively increase plasma fibrinolytic activity and either restore (in t-PA-deficient mice) or augment (in PAI-1-overexpressing mice) the thrombolytic capacity in simple animal models of defective fibrinolysis.

Authors+Show Affiliations

Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, KU Leuven, Belgium.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

9269770

Citation

Carmeliet, P, et al. "Adenovirus-mediated Transfer of Tissue-type Plasminogen Activator Augments Thrombolysis in Tissue-type Plasminogen Activator-deficient and Plasminogen Activator Inhibitor-1-overexpressing Mice." Blood, vol. 90, no. 4, 1997, pp. 1527-34.
Carmeliet P, Stassen JM, Van Vlaenderen I, et al. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood. 1997;90(4):1527-34.
Carmeliet, P., Stassen, J. M., Van Vlaenderen, I., Meidell, R. S., Collen, D., & Gerard, R. D. (1997). Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood, 90(4), pp. 1527-34.
Carmeliet P, et al. Adenovirus-mediated Transfer of Tissue-type Plasminogen Activator Augments Thrombolysis in Tissue-type Plasminogen Activator-deficient and Plasminogen Activator Inhibitor-1-overexpressing Mice. Blood. 1997 Aug 15;90(4):1527-34. PubMed PMID: 9269770.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. AU - Carmeliet,P, AU - Stassen,J M, AU - Van Vlaenderen,I, AU - Meidell,R S, AU - Collen,D, AU - Gerard,R D, PY - 1997/8/15/pubmed PY - 1997/8/15/medline PY - 1997/8/15/entrez SP - 1527 EP - 34 JF - Blood JO - Blood VL - 90 IS - 4 N2 - Impaired fibrinolysis, resulting from increased plasminogen activator inhibitor-1 (PAI-1) or reduced tissue-type plasminogen activator (t-PA) plasma levels, may predispose the individual to subacute thrombosis in sepsis and inflammation. The objective of these studies was to show that adenovirus-mediated gene transfer could increase systemic plasma t-PA levels and thrombolytic capacity in animal model systems. Recombinant adenovirus vectors were constructed that express either human wild type or PAI-1-resistant t-PA from the cytomegalovirus (CMV) promoter. Both t-PA-deficient (t-PA(-/-)) and PAI-1-overexpressing transgenic mice were infected by intravenous injection of these viruses. Intravenous injection of recombinant adenovirus resulted in liver gene transfer, t-PA synthesis, and secretion into the plasma. Virus dose, human t-PA antigen, and activity concentrations in plasma and extent of lysis of a 125I-fibrin-labeled pulmonary embolism were all closely correlated. Plasma t-PA antigen and activity were increased approximately 1,000-fold above normal levels. Clot lysis was significantly increased in mice injected with a t-PA-expressing virus, but not in mice injected with saline or an irrelevant adenovirus. Comparable levels of enzyme activity and clot lysis were obtained with wild type and inhibitor-resistant t-PA viruses. Adenovirus-mediated t-PA gene transfer was found to augment clot lysis as early as 4 hours after infection, but expression levels subsided within 7 days. Adenovirus-mediated transfer of a t-PA gene can effectively increase plasma fibrinolytic activity and either restore (in t-PA-deficient mice) or augment (in PAI-1-overexpressing mice) the thrombolytic capacity in simple animal models of defective fibrinolysis. SN - 0006-4971 UR - https://www.unboundmedicine.com/medline/citation/9269770/Adenovirus_mediated_transfer_of_tissue_type_plasminogen_activator_augments_thrombolysis_in_tissue_type_plasminogen_activator_deficient_and_plasminogen_activator_inhibitor_1_overexpressing_mice_ L2 - http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=9269770 DB - PRIME DP - Unbound Medicine ER -